Humana Story

H
HUM -- USA Stock  

USD 401.04  7.15  1.75%

Humana Inc is scheduled to announce its earnings today. The next earnings report is expected on the 3rd of February 2021. Because some of us are getting excited about healthcare space, it makes sense to summarize Humana Inc in greater detail. We will evaluate why we are still optimistic in anticipation of a recovery.
Published over two weeks ago
View all stories for Humana | View All Stories
Should analysts change their consensus on Humana (NYSE:HUM) after the new hike?
The company retains a Market Volatility (i.e. Beta) of 0.0043, which attests to not very significant fluctuations relative to the market. Let's try to break down what Humana's beta means in this case. As returns on the market increase, Humana returns are expected to increase less than the market. However, during the bear market, the loss on holding Humana will be expected to be smaller as well. Even though it is essential to pay attention to Humana Inc current price history, it is always good to be careful when utilizing equity current price movements. Our philosophy towards determining any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Humana Inc exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Humana Inc has an expected return of -0.0036%. Please be advised to check out Humana semi variance, and the relationship between the treynor ratio and daily balance of power to decide if Humana Inc stock performance from the past will be repeated at some point in the near future.
What is the right price you would pay to acquire a share of Humana? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated. Please read more on our stock advisor page.

What is happening with Humana Inc this year

Annual and quarterly reports issued by Humana Inc are formal financial statements that are published yearly and quarterly and sent to Humana stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the Securities and Exchange Commission (SEC) for businesses owned by the public since 1934. Companies such as Humana often view their annual report as an effective marketing tool to disseminate their perspective on company future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.

How Humana utilizes its cash?

To perform a cash flow analysis of Humana, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Humana is receiving and how much cash it distributes out in a given period. The Humana cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Humana Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at 5.7 Billion

Breaking it down a bit more

Earning per share calculations of the firm is based on official Zacks consensus of 10 analysts regarding Humana's future annual earnings. Given the historical accuracy of 93.73%, the future earnings per share of the company is estimated to be 19.035 with the lowest and highest values of 18.51 and 21.42, respectively. Please note that this consensus of annual earnings estimates for Humana Inc is an estimate of EPS before non-recurring items and including employee stock options expenses.

Is Humana a risky opportunity?

Let's check the volatility. Humana is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Humana (NYSE:HUM) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. acquiring a share of a Humana stock makes you a part-owner of that company.

Humana Inc Current Consensus

Here is the new trade recommendation based on an ongoing consensus estimate among financial analysis covering Humana Inc. The Humana consensus assessment is calculated by taking the average estimates from all of the analysts covering Humana

Strong Buy
10
Buy
1
Hold
4
Strong Buy1066.67
Buy16.67
Hold426.67
Sell00.0
Strong Sell00.0

Our take on today Humana hike

New value at risk is at -3.03. Humana Inc has relatively low volatility with skewness of -0.06 and kurtosis of 0.22. However, we advise all investors to independently investigate Humana Inc to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns.

When is the right time to buy or sell Humana Inc? Buying stocks such as Humana isn't very hard. However, what challenging for most investors is doing it at the right time. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities, deliver winning trades and diversify portfolios on a daily bases. To conclude, as of the 3rd of November 2020, we see that Humana barely shadows the market. The company is fairly valued with very small chance of financial distress within the next 24 months. Our primary 30 days buy-or-sell advice on the company is Strong Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Humana Inc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com